Status: Recruiting
Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients
The phenotype of circulating tumor cells (CTCs) is supposed to be significant indicator that is correlated the prognosis of breast cancer patients who have completed neoadjuvant chemotherapy, primary tumor surgery with/without adjuvant chemotherapy. The aim of this observational study is to assess the efficacy of CTCs surveillance in predicting the prognosis of breast cancer patients.
Participants needed: 1,000
Trial details
Age: 18-75Biological sex: FemaleType: ObservationalSponsor: Hunan Cancer HospitalUpdated: Apr 13, 2022Locations: 1
Eligibility criteria
The age is more than 18 years old; [+5]
Patients who had suffered from other malignant tumors; [+5]